NEW YORK, Feb. 27 (GenomeWeb News) - Tm Bioscience has received conditional approval to list its common shares on the Toronto Stock Exchange, the company said yesterday.
The Toronto-based company expects full approval by May 26. CEO and president Greg Hines said he hopes the listing will "greatly enhance our profile among a broader group of investors."
Tm Bioscience also plans to consolidate its shares by converting each five common shares into one. It intends to obtain shareholder approval for this share consolidation at its annual meeting, scheduled for June 2.